FDA Grants No Labeling Privileges To “Convenience-Size” Cosmetic-Drugs
This article was originally published in The Rose Sheet
Executive Summary
FDA's proposed rule on labeling requirements for over-the-counter drug products does not address CTFA's repeated contention that "convenience-size" items earmarked for exemptions should include topical OTC drugs with no dosage limitations
You may also be interested in...
OTC Labeling Compliance Date Delayed For “Convenience-Size” Items
"Convenience-size" OTC drugs will not be required to meet "Drug Facts" reg compliance dates until FDA publishes either a final rule or further notice on the labeling of such products
Unilever’s Dove Recommits To ‘Real Women’ Against Rising AI Threat
Unilever PLC’s Dove and Baby Dove brands continue tackling prominent social causes with a vow to be responsible about representing women realistically in advertising in the age of AI and a renewed commitment to closing the Black maternal care gap.
L’Oreal Joins J&J And Major Retailers Defending Benzene Class Actions In Federal Courts
Benzoyl peroxide-based acne drug products and their alleged proclivity to become contaminated with carcinogenic benzene are at the center of putative class actions filing against L’Oreal in federal courts around the US.